IL17A and acute respiratory distress syndrome: Moreover, in the ARDS inflammatory process, IL-17A (the most studied subtype of IL-17) acts on macrophages, resulting in increased expression of NO synthase, IL-1, IL-6, TNFα, and chemokines, which makes the disease worse.